Internal Medicine · Pittsburgh, PA
NPI
1023514874
Since 2018
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
310 Rodi Rd Ste 100
Pittsburgh, PA, 15235
Phone (412) 242-0777
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,877
351 services
Medicare patients, 2024
142
Average age 75
Drug cost, 2024
$1.8M
16,591 prescriptions
Company payments, 2025
$853
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy G Rabe was code 82962 (clinical chemistry), 141 times for 82 patients. In total Timothy G Rabe billed 351 services in 9 codes, and Medicare paid $4,877.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 141 | 82 | $3.21 | $453 |
| 83036 Blood Count | Office | 103 | 76 | $9.52 | $981 |
| 93005 Electrocardiogram | Office | 26 | 26 | $3.30 | $85.83 |
| 87636 Infectious Agent Detection by DNA/RNA | Office | 18 | 15 | $139.78 | $2,516 |
| 87635 COVID Specific | Office | 11 | 11 | $50.28 | $553 |
By year: 2022 $2,616 for 82 services; 2023 $5,471 for 217 services; 2024 $4,877 for 351 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 141 | 82 | $3.21 | $453 |
| 83036 Blood Count | 103 | 76 | $9.52 | $981 |
| 87636 Infectious Agent Detection by DNA/RNA | 18 | 15 | $139.78 | $2,516 |
| 87635 COVID Specific | 11 | 11 | $50.28 | $553 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy G Rabe prescribed most often to Medicare patients was Atorvastatin Calcium, with 752 prescriptions and refills. In total Timothy G Rabe wrote 16,591 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 752 | 1,627 | 178 | $6,960 |
| Amlodipine Besylate Generic | 624 | 1,305 | 145 | $2,981 |
| Rosuvastatin Calcium Generic | 517 | 1,104 | 122 | $4,201 |
| Omeprazole Generic | 492 | 933 | 109 | $5,548 |
| Furosemide Generic | 386 | 714 | 101 | $1,600 |
| Levothyroxine Sodium Generic | 359 | 729 | 69 | $3,971 |
| Pravastatin Sodium Generic | 346 | 743 | 79 | $3,937 |
| Felodipine Er Felodipine | 334 | 640 | 67 | $7,932 |
| Losartan Potassium Generic | 327 | 742 | 78 | $2,617 |
| Lisinopril Generic | 318 | 650 | 68 | $2,334 |
| Hydrochlorothiazide Generic | 316 | 719 | 78 | $851 |
| Gabapentin Generic | 303 | 519 | 70 | $4,045 |
| Celecoxib Generic | 292 | 364 | 84 | $5,665 |
| Pantoprazole Sodium Generic | 290 | 560 | 72 | $2,500 |
| Metformin Hcl Generic | 282 | 542 | 62 | $1,441 |
Brand drugs: 2,359 claims; generic drugs: 14,135 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy G Rabe $853 ($853 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $168.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $168 |
| Novo Nordisk Inc NVO | 11 | $163 |
| Amgen Inc. AMGN | 11 | $143 |
| GlaxoSmithKline, LLC. GSK | 5 | $91.13 |
| Abbvie Inc. ABBV | 3 | $65.41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46.76 |
| Exact Sciences Corporation EXAS | 2 | $46.3 |
| Corcept Therapeutics CORT | 2 | $39.25 |
| Lilly USA, LLC LLY | 2 | $31.36 |
| Medtronic, Inc. MDT | 1 | $23.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.